HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dietary supplementation of silymarin protects against chemically induced nephrotoxicity, inflammation and renal tumor promotion response.

Abstract
Ferric nitrilotriacetate (Fe-NTA) is a potent nephrotoxicant and a renal carcinogen that induces its effect by causing oxidative stress. The present study was undertaken to explore protective effect of silymarin, a flavonolignan from milk thistle (Silybum marianum), against Fe-NTA mediated renal oxidative stress, inflammation and tumor promotion response along with elucidation of the implicated mechanism(s). Administration of Fe-NTA (10 mg/kg bd wt, i.p.) to Swiss albino mice induced marked oxidative stress in kidney, evident from augmentation in renal metallothionein (MT) expression, depletion of glutathione content and activities of antioxidant and phase II metabolizing enzymes, and enhancement in production of aldehyde products such as 4-hydroxy-2-nonenal. Fe-NTA also significantly activated nuclear factor kappa B (NFkappaB) and upregulated the expression of downstream genes: cyclooxygenase 2 and inducible nitric oxide synthase and enhancing the production of proinflammatory cytokines: tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6). However, feeding of 0.5% and 1% silymarin diet conferred a significant protection against Fe-NTA induced oxidative stress and inflammation. It further augmented MT expression, restored the antioxidant armory, ameliorated NFkappaB activation and decreased the expression of proinflammatory mediators. Silymarin also suppressed Fe-NTA induced hyperproliferation in kidney, ameliorating renal ornithine decarboxylase activity and DNA synthesis. From these results, it could be concluded that silymarin markedly protects against chemically induced renal cancer and acts plausibly by virtue of its antioxidant, anti-inflammatory and antiproliferative activities.
AuthorsGurpreet Kaur, Mohammad Athar, M Sarwar Alam
JournalInvestigational new drugs (Invest New Drugs) Vol. 28 Issue 5 Pg. 703-13 (Oct 2010) ISSN: 1573-0646 [Electronic] United States
PMID19590824 (Publication Type: Journal Article)
Chemical References
  • Aldehydes
  • Antioxidants
  • Cytokines
  • DNA, Neoplasm
  • Ferric Compounds
  • Inflammation Mediators
  • NF-kappa B
  • Protective Agents
  • Silymarin
  • Metallothionein
  • Nitric Oxide Synthase Type II
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Ornithine Decarboxylase
  • 4-hydroxy-2-nonenal
  • Nitrilotriacetic Acid
  • ferric nitrilotriacetate
Topics
  • Aldehydes (metabolism)
  • Animals
  • Antioxidants (metabolism)
  • Cyclooxygenase 2 (metabolism)
  • Cytokines (blood)
  • DNA, Neoplasm (biosynthesis)
  • Dietary Supplements
  • Female
  • Ferric Compounds (pharmacology)
  • Inflammation (blood, complications, drug therapy)
  • Inflammation Mediators (blood)
  • Kidney (drug effects, enzymology, pathology)
  • Kidney Neoplasms (blood, complications, drug therapy, enzymology)
  • Lipid Peroxidation (drug effects)
  • Metabolic Detoxication, Phase II
  • Metallothionein (metabolism)
  • Mice
  • NF-kappa B (metabolism)
  • Nitric Oxide Synthase Type II (metabolism)
  • Nitrilotriacetic Acid (analogs & derivatives, pharmacology)
  • Ornithine Decarboxylase (metabolism)
  • Protective Agents (therapeutic use)
  • Silymarin (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: